Research programme: cyclin-dependant kinases - Virostatics

Drug Profile

Research programme: cyclin-dependant kinases - Virostatics

Alternative Names: VS2 370

Latest Information Update: 30 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Virostatics
  • Class Antineoplastics; Antivirals; Small molecules
  • Mechanism of Action Cyclin dependent kinase 9 inhibitors; Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer; HIV infections
  • Research Epstein-Barr virus infections; Hepatitis B; Varicella zoster virus infections
  • Discontinued Ebola virus infections; Herpes simplex virus type 1 infections; Herpes simplex virus type 2 infections; Human papillomavirus infections

Most Recent Events

  • 30 Jun 2017 Discontinued for Ebola virus infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
  • 30 Jun 2017 Discontinued for Herpes simplex virus type-1 infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
  • 30 Jun 2017 Discontinued for Herpes simplex virus type-2 infections in Italy (PO) as the indication is not listed on the pipeline (Virostatics pipeline, June 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top